Navigation Links
BCC Research: PPACA, Demand in Emerging Markets Shape Growth in Healthcare for Foreseable Future
Date:11/11/2013

Wellesley, Mass. (PRWEB) November 11, 2013

The Patient Protection and Affordable Healthcare Act (PPACA) of 2010, will have a significant impact on the market for various medical and assistive technologies. Among its other provisions, the new law imposes a tax on medical devices such as prosthetic limbs, pacemakers, and wheelchairs which will increase the cost of these devices and may decrease their use. Additionally, PPACA contains various other provisions that could have a significant impact on the market for assistive technologies, particularly through changes in Medicare. However, demand for medical and healthcare services, including therapeutic and diagnostic screenings, is expected to rise dramatically in the emerging markets as more individuals acquire coverage and the global economy continues to improve.

Medical device manufacturers, diagnostic developers, and individuals must understand these developments in order to capture new opportunities in both domestic and international markets. BCC Research's technical market research reports provide invaluable insights into this dynamic market.

Use BCC Research reports to:

Gain an overview of a wide range of healthcare market segments, including medical devices, diagnostic and therapeutic tools, and other emerging technologies.
Analyze five-year market trends with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018.
Evaluate commercial applications for healthcare products, including medical devices, diagnostic and therapeutic tools, and other emerging technologies.
Assess the impact of industry standards and governmental regulations on both the regional and global markets.
Review comprehensive company profiles of the top industry players and relative market shares for leading companies.

BCC Research's technical healthcare market research reports are intended for marketing and management executives within the medical device industry, suppliers to this industry, venture capital professionals interested in exploring commercialization opportunities, and anyone else who wishes to understand how market factors and technologies interact in this industry.

Recently Published Reports:

HLC076B - Cardiovascular Surgical Devices: Technologies and Global Markets
Whether through disease, congenital defects or loss of cardiac and vascular function, the incidence of cardiovascular disease is growing dramatically, spurring continued growth in cardiovascular surgical procedures. In recent years, new technologies have been developed that make sophisticated therapies accessible for patients in previously underserved locations. Medical advances, aging populations, increasing rates of obesity, and poor nutrition will drive significant growth in this market for the foreseeable future. (October 2013)

HLC142A - Therapies and Diagnostics for Uterine Cancer
According to the American Cancer Society, more than 47,000 new cases of uterine or endometrial, cancer were diagnosed and 8,010 women died from the disease in 2012 alone. While there are currently no approved drugs for endometrial cancer, researchers are examining new drugs, combinations of drugs, and targeted therapies at various stages of pipeline development. Growth in this market is primarily driven by an increase in the prevalence rates of the disease due to the aging population, diabetes, and obesity. (September 2013)

HLC078B - Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
As magnetic resonance imaging (MRI) becomes a standard in diagnostic healthcare; innovation, higher tesla strength, new applications, and the development of MRI systems that maximize diagnostic equipment usage will continue to drive growth in this market. In addition, the introduction of MRI technology to previously underserved populations outside of the U.S., Europe, and Japan as well as increased utilization reimbursement rates will provide manufacturers with expanded opportunities for the foreseeable future. (September 2013)

HLC079B - Technologies for Long-Term Care and Home Healthcare: Global Markets
Emerging telehealth and safety-monitoring technologies hold the promise of enormous cost savings for the healthcare system by enhancing the ability of providers to deliver timely intervention prior to a patient’s deterioration. Consequently, a rapidly aging population, the necessity to cut costs in the delivery of care, and further adoption of technology and broadband connectivity by seniors will fuel future demand for this market. (August 2013)

HLC047D - Disabled and Elderly Assistive Technologies
Increasing numbers of disabled and elderly people are living longer and more-independent lives. These changes have coincided with dramatic shifts in public and professional attitudes toward the disabled and the elderly. Advances in medical science, technology and healthcare, combined with demographic trends, societal evolution and changing attitudes will drive this market over the near term. (June 2013)

Upcoming Reports:

HLC154A - Surgical Equipment: Technologies and Global Markets
This technical market research report will provide an overview of the global market for surgical equipment, which is undergoing significant changes with technology innovations such as surgical robotics, the introduction of powered surgical tools, and a significant focus on minimally invasive procedures. (November 2013)

HLC146A - Global Markets and Technologies for Molecular Imaging Devices
This report will provide an overview of the global market for molecular imaging devices, which offers a new dimension to medicine as it evolves toward personalized forms of treatment. (November 2013)

Read the full story at http://www.prweb.com/releases/2013/11/prweb11320600.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved
2. BioMed Central presents Challenges in Malaria Research: Progress Towards Elimination
3. Research: NCAA football exploits players in invisible labor market
4. Kinsey research: Postpartum women less stressed by threats unrelated to the baby
5. Research: Lupus drugs carry no significant cancer risk for patients
6. Research: Military women may have higher risk for STIs
7. Gut microbiota research: Pinpointing a moving target
8. Research: Brain cant cope with making a left-hand turn and talking on hands-free cell phone
9. UTHealth research: Low incidence of venous insufficiency in MS
10. Multiple sclerosis research: The thalamus moves into the spotlight
11. Research: Women over 40 still need effective contraception
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other ... loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store ... to remind them of the lives they’ve led and the people they’ve touched. ...
(Date:2/8/2016)... ... 08, 2016 , ... Tingley Rubber Corporation , a ... its range of unique and advantaged protective solutions to a growing and ... bilingual customer service and marketing support. A new distribution center in Brampton, Ontario ...
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California ... combat pancreatic cancer. , Gary D. Radine, who recently retired as president and CEO ... Cancer Society’s 2015 CEO of the Year , helped lead the effort to ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... , ... February 08, 2016 , ... TopConsumerReviews.com recently awarded ... Mole removal products. , Moles are derived from a cluster of melanin when exposed ... the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... CITY, Calif., Feb. 8, 2016  Aoxing Pharmaceutical Company, Inc. (NYSE ... fiscal year 2016, ended December 31, 2015, the Company achieved ... recorded in the same quarter in fiscal 2015. ... in Q2 of fiscal year 2016 was $2,068,635, or $.03 ... or $.01 per share, in the Q2 of fiscal year ...
(Date:2/8/2016)... Feb. 8, 2016 ... of the "Label-Free Detection Market by ... 2020" report to their offering. ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
Breaking Medicine Technology: